Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma.

Yang YB, Wu CY, Wang XY, Deng J, Cao WJ, Tang YZ, Wan CC, Chen ZT, Zhan WY, Shan H, Kuang DM, Wei Y
Mol Ther. 2023 Jan 4;31(1):105-118. doi: 10.1016/j.ymthe.2022.09.019. Epub 2022 Sep 30. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.